BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$90.02 USD
0.00 (0.00%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $90.00 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $0.77 | 0.68% |
Earnings Summary
For their last quarter, BioMarin Pharmaceutical (BMRN) reported earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.57 per share. This reflects a positive earnings surprise of 68.42%. Look out for BMRN's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of $0.77 per share, reflecting a year-over-year increase of 67.39%.
Earnings History
Price & Consensus
Zacks News for BMRN
Bristol Myers' (BMY) Breyanzi Label Expansion Application Validated
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services